| Date Filed | Type | Description |
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2022 |
4
| Panzara Michael A. (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 2,311 options to buy
@ $8.93, valued at
$20.6k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2022 |
4
| Panzara Michael A. (Director) has filed a Form 4 on Athira Pharma, Inc.|
Txns:
| Granted 27,742 options to buy
@ $10.62, valued at
$294.6k
|
|
| 03/21/2022 |
3
| Panzara Michael A. (Director) has filed a Form 3 on Athira Pharma, Inc. |
| 02/18/2022 |
4
| Panzara Michael A. (See Remarks) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Sold 10,603 shares
@ $2.31, valued at
$24.5k
|
|
| 01/04/2022 |
4
| Panzara Michael A. (See Remarks) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 200,000 options to buy
@ $3.14, valued at
$628k
|
|
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/05/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2019 |
4
| Panzara Michael A. (Chief Medical Officer) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Sold 2,613 shares
@ $26.88, valued at
$70.2k
Sold 445 shares
@ $27.26, valued at
$12.1k
|
|
| 03/11/2019 |
4
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 15,000 shares
@ $0
Sold 7,000 shares
@ $48, valued at
$336k
|
|
| 02/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2018 |
4
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Sold 511 shares
@ $52.1, valued at
$26.6k
|
|
| 02/20/2018 |
4
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Sold 18,750 shares
@ $50, valued at
$937.5k
Exercised 18,750 options to buy
@ $21.69, valued at
$406.7k
|
|
| 01/25/2018 |
4
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 17,500 shares
@ $0
Granted 35,000 options to buy
@ $40.05, valued at
$1.4M
|
|
| 07/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/13/2016 |
4
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 4 on Wave Life Sciences Ltd.|
Txns:
| Granted 22,750 shares
@ $0
Granted 150,000 options to buy
@ $21.69, valued at
$3.3M
|
|
| 07/13/2016 |
3
| Panzara Michael A. (Franchise Lead, Neurology) has filed a Form 3 on Wave Life Sciences Ltd. |